← Eichor
Condition: Anemia Of Pregnancy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anemia Of Pregnancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Phase N/A · 1 location(s) · Institute of Mother and Child, Warsaw, Poland · NCT06984445Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intr
NA · 1 location(s) · Boston Children's Hospital · NCT06056635Non-invasive Detection of Iron Deficiency in Obstetrics
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT07083492Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Phase 2 · 1 location(s) · University of Washington · NCT05340465Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
NA · 1 location(s) · European Institute of Oncology · NCT06785077A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatmen
Phase 3 · 21 location(s) · AMAG Pharmaceuticals, Inc. · NCT03619850Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07076849Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644Efficacy of INM004 in Children With STEC-HUS
Phase 3 · 52 location(s) · Inmunova S.A. · NCT06389474Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy
Phase 3 · 1 location(s) · Saskatchewan Health Authority - Regina Area · NCT05251493The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Mu
Phase N/A · 8 location(s) · AstraZeneca · NCT07218536A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06653556Hepcidin and Glucose Metabolism
NA · 1 location(s) · Swiss Federal Institute of Technology · NCT04008147Cooperative Assessment of Late Effects for SCD Curative Therapies
Phase N/A · 5 location(s) · Vanderbilt University Medical Center · NCT05153967A Prediction Model in Pregnant Women With Aplastic Anemia
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07101770Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
Phase 4 · 1 location(s) · Southern Illinois University · NCT06492512Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Phase 3 · 9 location(s) · Novartis Pharmaceuticals · NCT05795140Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron Status
Phase 3 · 2 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06568315Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypi
Phase 3 · 31 location(s) · Novartis Pharmaceuticals · NCT05935215Iron Status of Non-anemic Pregnant Women in First Trimester
Phase N/A · 1 location(s) · Hung Vuong Hospital · NCT06990373Oral Iron in Children With Chronic Kidney Disease
Phase 4 · 2 location(s) · Weill Medical College of Cornell University · NCT03991169Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Dise
Phase 3 · 2 location(s) · Biocad · NCT07119372Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm
NA · 9 location(s) · Nemours Children's Clinic · NCT06240715Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
Phase 4 · 12 location(s) · Alexion Pharmaceuticals, Inc. · NCT07308574Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy
NA · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT05805202
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.